20

© Zühlke 2014

© Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

Download PDF Report

Upload
others
View
0
Download
0

Embed Size (px)

Citation preview

Page 1: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 2: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 3: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 4: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 5: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 6: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 7: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 8: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 9: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 10: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 11: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014 Source: embeddedsystemnews.com

Page 12: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 13: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

C

Page 14: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 15: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

2G

3G

4G

Page 16: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 17: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 18: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Safety & Security 2

Page 19: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Page 20: © Zühlke 2014 · aspart Injection v origin) 100 (U-100) t: see in a cold freezing. OK . Created Date: 10/20/2014 12:50:14 PM

© Zühlke 2014

Nothing New Under the Sun - GOTO Blog • GOTO …gotocon.com/dl/goto-cph-2011/slides/KeithBraithwaite... · · 2011-05-11Nothing New Under the Sun © Zühlke 2010 21 July 2009

Nothing New Under the Sun - GOTO Blog • GOTO …gotocon.com/dl/goto-cph-2011/slides/KeithBraithwaite... · · 2011-05-11Nothing New Under the Sun © Zühlke 2010 21 July 2009

Documents

Christian Moser User Experience Architect Zühlke Engineering AG Expression Blend 4 – deep dive

Christian Moser User Experience Architect Zühlke Engineering AG Expression Blend 4 – deep dive

Documents

NovoRapid, INN-insulin aspart · NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch 1 užpildytame švirkštiklyje yra 3 ml, atitinkantys 300 vienetų. 1 ml tirpalo yra 100 vienetų

NovoRapid, INN-insulin aspart · NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch 1 užpildytame švirkštiklyje yra 3 ml, atitinkantys 300 vienetų. 1 ml tirpalo yra 100 vienetų

Documents

tec News - Harting · smart infrastructures 6 Our guest article: tec.News 21: Strategy » Prof. Dr.-Ing. Detlef Zühlke, Scientific Director, German Research Center for Artificial

tec News - Harting · smart infrastructures 6 Our guest article: tec.News 21: Strategy » Prof. Dr.-Ing. Detlef Zühlke, Scientific Director, German Research Center for Artificial

Documents

NovoMix, INN-insulin aspart

NovoMix, INN-insulin aspart

Documents

Insulin aspart Sanofi, INN-insulin aspart · The applicant sanofi-aventis groupe submitted on 29 May 2019 an application for marketing authorisation to the European Medicines Agency

Insulin aspart Sanofi, INN-insulin aspart · The applicant sanofi-aventis groupe submitted on 29 May 2019 an application for marketing authorisation to the European Medicines Agency

Documents

ZV-SOMMERCAMP 2017 › custom › download › 2017 › ... · Funke Digital, Berlin ... Tlgg – Experten für Digitale Transformation florian Zühlke, head of content und community

ZV-SOMMERCAMP 2017 › custom › download › 2017 › ... · Funke Digital, Berlin ... Tlgg – Experten für Digitale Transformation florian Zühlke, head of content und community

Documents

BILAGA I PRODUKTRESUMÉ - European Commission...NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch 1 ml lösning innehåller 100 enheter insulin aspart* (vilket motsvarar 3,5

BILAGA I PRODUKTRESUMÉ - European Commission...NovoRapid FlexPen/NovoRapid InnoLet/NovoRapid FlexTouch 1 ml lösning innehåller 100 enheter insulin aspart* (vilket motsvarar 3,5

Documents

Novo Nordisk Pharma, Inc. INSULIN ASPART- insulin aspart

Novo Nordisk Pharma, Inc. INSULIN ASPART- insulin aspart

Documents

HTML5 or native? - gotocon.comgotocon.com/dl/goto-zurich-2013/slides/NikolaosKaintantzis_HTML5Versus... · © Zühlke 2013 Nikolaos Kaintantzis Deciding right for your needs Mobile:

HTML5 or native? - gotocon.comgotocon.com/dl/goto-zurich-2013/slides/NikolaosKaintantzis_HTML5Versus... · © Zühlke 2013 Nikolaos Kaintantzis Deciding right for your needs Mobile:

Documents

Current Trends in Diagnosis and Management of Gestational ... · Which insulin to use in pregnancy? Regular insulin (U-100 and U-500), insulin aspart, insulin lispro, NPH and insulin

Current Trends in Diagnosis and Management of Gestational ... · Which insulin to use in pregnancy? Regular insulin (U-100 and U-500), insulin aspart, insulin lispro, NPH and insulin

Documents

Insulin Aspart Mix PI · Insulin Aspart Protamine and Insulin Aspart Injectable Suspension 2 5.5 Hypersensitivity and Allergic Reactions Severe, life-threatening, generalized allergy,

Insulin Aspart Mix PI · Insulin Aspart Protamine and Insulin Aspart Injectable Suspension 2 5.5 Hypersensitivity and Allergic Reactions Severe, life-threatening, generalized allergy,

Documents

© Zühlke 2014 Tobias Kniep Effective Internationalization for Embedded Systems 26. February 2014

© Zühlke 2014 Tobias Kniep Effective Internationalization for Embedded Systems 26. February 2014

Documents

The Zühlke Software Development Process

The Zühlke Software Development Process

Technology

Insulin degludec/insulin aspart versus biphasic insulin

Insulin degludec/insulin aspart versus biphasic insulin

Documents

Australian Public Assessment Report for Insulin aspart (rys) · 1 NovoRapid insulin aspart is a rapid acting insulin used to treat diabetes mellitus, registered on the Australian

Australian Public Assessment Report for Insulin aspart (rys) · 1 NovoRapid insulin aspart is a rapid acting insulin used to treat diabetes mellitus, registered on the Australian

Documents

insulin aspart injection 100 units/mL · FIASP® (insulin aspart injection) 100 U/mL 2 cemia usually reflects the time-action profile of the administered insulin formulation. As with

Documents

RYZODEG® 70/30 (insulin degludec and insulin aspart … · · 2015-09-2970/30 (insulin degludec and insulin aspart injection), ... • Administer subcutaneously once or twice daily

RYZODEG® 70/30 (insulin degludec and insulin aspart … · · 2015-09-2970/30 (insulin degludec and insulin aspart injection), ... • Administer subcutaneously once or twice daily

Documents

Metro-Style Apps mit Expression Blend 5 für HTML designen Christian Moser User Experience Designer Zühlke Engineering AG moc@zuehlke.com

Metro-Style Apps mit Expression Blend 5 für HTML designen Christian Moser User Experience Designer Zühlke Engineering AG [email protected]

Documents

15 Years of Experience with Biphasic Insulin Aspart 30 in ... · Abstract Since clinical experience with biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes mellitus (T2DM) was

15 Years of Experience with Biphasic Insulin Aspart 30 in ... · Abstract Since clinical experience with biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes mellitus (T2DM) was

Documents

CPyF‑AcIAt VInsulin AMeasurFree or˜TIARtion tAn ... · Faster Aspart P easured as ree or Total nsulin Aspart 641 ClinicalTrials.gov:NCT01618188(Trial1),NCT02003677 (Trial2),NCT01934712(Trial3),NCT02568280(Trial4)

CPyF‑AcIAt VInsulin AMeasurFree or˜TIARtion tAn ... · Faster Aspart P easured as ree or Total nsulin Aspart 641 ClinicalTrials.gov:NCT01618188(Trial1),NCT02003677 (Trial2),NCT01934712(Trial3),NCT02568280(Trial4)

Documents

Q Fever - Clinical Microbiology Reviews · Q FEVER 195 resolvingin 1 to 2weeks. Rarecomplications thatcanoccur aspart oftheinitial illness includeencephalitis, pericarditis, myocarditis,

Q Fever - Clinical Microbiology Reviews · Q FEVER 195 resolvingin 1 to 2weeks. Rarecomplications thatcanoccur aspart oftheinitial illness includeencephalitis, pericarditis, myocarditis,

Documents

Clinical Review Insulin Degludec-Insulin Aspart Clinical Prea...Tania A. Condarco, M.D. November 4, 2016 Insulin degludec Insulin degludec/insulin aspart 70/30 Tresiba for insulin

Clinical Review Insulin Degludec-Insulin Aspart Clinical Prea...Tania A. Condarco, M.D. November 4, 2016 Insulin degludec Insulin degludec/insulin aspart 70/30 Tresiba for insulin

Documents

Fast-Acting Insulin Aspart: A Review of its ...06 01 20 1802 40 300 0 50 100 150 200 250 300 Time since injection (minutes) Se ru mI As p co nc entr at io n(pm o ... (bothp < 0.001).AUC

Fast-Acting Insulin Aspart: A Review of its ...06 01 20 1802 40 300 0 50 100 150 200 250 300 Time since injection (minutes) Se ru mI As p co nc entr at io n(pm o ... (bothp < 0.001).AUC

Documents

Developer Day Designing Windows Store Apps with Expression Blend Christian Moser Developer and Designer, Zühlke moc@zuehlke.com

Developer Day Designing Windows Store Apps with Expression Blend Christian Moser Developer and Designer, Zühlke [email protected]

Documents

Dispensing Solutions, Inc. NOVOLOG- insulin aspart

Dispensing Solutions, Inc. NOVOLOG- insulin aspart

Documents

Package Leaflet: Information for the User Insulin aspart

Package Leaflet: Information for the User Insulin aspart

Documents

Cloud Lösungen und HoloLens für ... - info.microsoft.com in... · Serviceleisungen tracken und effizient erbringen | Dennis Ahrens - Business Solution Manager Zühlke Engineering

Cloud Lösungen und HoloLens für ... - info.microsoft.com in... · Serviceleisungen tracken und effizient erbringen | Dennis Ahrens - Business Solution Manager Zühlke Engineering

Documents

companion specifications and equipment specific Fabian Stoop* · transformation to the smart factory (Radziwon et al., 2014). As mentioned by Kolberg and Zühlke (2015), it is already

companion specifications and equipment specific Fabian Stoop* · transformation to the smart factory (Radziwon et al., 2014). As mentioned by Kolberg and Zühlke (2015), it is already

Documents

Digital Transformation by Zühlke

Digital Transformation by Zühlke

Business